Koru Medical Systems Inc (KRMD) Stock Price, Quote & News

Company Profile

KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobin...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 845-469-2042

Fax: 845 469 5518

Website: www.korumedical.com

Address:

100 Corporate Drive, Mahwah, United States

Doozio Oct. 23 at 1:20 PM

$KRMD it was always chop chop huckleberries 🐒🍌🧠⏰♾️

0 · Reply

StockChartsStudyholic Oct. 14 at 9:37 PM

$KRMD 👀

0 · Reply

IPO_Candy Oct. 10 at 8:36 PM

$KRMD Oh a green one!

0 · Reply

TradeNiko Oct. 5 at 9:27 AM

$KRMD Medical device innovation. Testing resistance at descending trendline. Volume pattern constructive for breakout.

0 · Reply

Gesundheit Sep. 16 at 2:21 PM

$KRMD Looks like we might hit another buy point. It is always sneaky and you have to be ready to hit or set a buy order.

0 · Reply

NVDAMillionaire Sep. 10 at 6:18 AM

$KRMD Excellent article that nails exactly where KRMD stands right now. So if you want to update your KRMD knowledge or get acquainted with KRMD, this is a must read. https://beyondspx.com/quote/KRMD/analysis/koru-medical-systems-nasdaq-krmd-unlocking-growth-through-subcutaneous-innovation-and-global-expansion

0 · Reply

IPO_Candy Aug. 25 at 3:49 PM

$KRMD Added this one to the long term portfolio a few months ago. A keeper.

0 · Reply

Thestocktraderhubzee Aug. 7 at 6:15 PM

$KRMD KORU Medical Systems shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY25 sales guidance above estimates.

0 · Reply

Gesundheit Aug. 7 at 2:01 AM

$KRMD Nice earnings... https://seekingalpha.com/news/4480681-koru-medical-systems-gaap-eps-of-000-beats-by-003-revenue-of-102m-beats-by-074m

0 · Reply

Gesundheit Jul. 15 at 8:04 PM

$KRMD This is where you really make serious money. Up and down is usually by about 1.00. Short can now safely be covered at around 2.60 then we will be good for another round. Almost as predictable as your money Market CD.

1 · Reply

KORU Medical Systems to Report Third Quarter 2025 Financial Results on November 12, 2025

Sep 18, 2025, 8:00 AM EDT - 5 weeks ago

ForCast Orthopedics and KORU Medical Systems Announce Agreement for Novel Antibiotic Infusion Therapy

Aug 28, 2025, 12:59 PM EDT - 2 months ago

Cirtec Medical Announces Appointment of New Chief Executive Officer

Aug 7, 2025, 3:23 AM EDT - 2 months ago

KORU Medical Systems, Inc. (KRMD) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 4:05 PM EDT - 2 months ago

KORU Medical Systems Announces Q2 2025 Financial Results, Including Record Double-digit Revenue, and Raises 2025 Revenue Guidance

Aug 1, 2025, 4:55 PM EDT - 3 months ago

KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Jul 30, 2025, 4:05 PM EDT - 3 months ago

KORU Medical Systems to Participate in the Canaccord Genuity 45th Annual Growth Conference

Jul 16, 2025, 4:05 PM EDT - 3 months ago

KORU Medical Systems to Report Second Quarter 2025 Financial Results on August 6, 2025

Jul 7, 2025, 4:05 PM EDT - 3 months ago

KORU Medical Systems Appoints Adam Kalbermatten as Chief Commercial Officer

Jun 11, 2025, 4:05 PM EDT - 4 months ago

KORU Medical Systems to Join Russell 3000® and Russell 2000® Indexes

May 11, 2025, 8:12 AM EDT - 5 months ago

KORU Medical Systems, Inc. (KRMD) Q1 2025 Earnings Call Transcript

May 7, 2025, 4:05 PM EDT - 6 months ago

KORU Medical Systems Announces Record Q1 2025 Financial Results and Raises 2025 Revenue Guidance

Mar 12, 2025, 10:34 PM EDT - 8 months ago

KORU Medical Systems, Inc. (KRMD) Q4 2024 Earnings Call Transcript

Mar 12, 2025, 4:05 PM EDT - 8 months ago

KORU Medical Systems Announces Fourth Quarter and Full Year 2024 Financial Results With Record Revenues and Gross Profit; Issues Full Year 2025 Guidance

Feb 19, 2025, 4:05 PM EST - 8 months ago

KORU Medical Systems to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025

Feb 10, 2025, 12:11 AM EST - 9 months ago

KORU Medical Systems Has A Long Runway

Feb 6, 2025, 4:05 PM EST - 9 months ago

KORU Medical Systems Announces Agreement for Next-Generation Subcutaneous Immunoglobulin Infusion System

Jan 30, 2025, 4:05 PM EST - 9 months ago

KORU Medical Systems Announces Phase III Clinical Trial Collaboration for a New Drug Indication in Nephrology

Jan 13, 2025, 8:00 AM EST - 10 months ago

KORU Medical Systems Reports Preliminary Fourth Quarter and Full Year 2024 Results; Achieves Record Full Year and Quarterly Revenues; Positive Cash Flow for the Fourth Quarter

Nov 25, 2024, 4:05 PM EST - 11 months ago

KORU Medical Systems to Participate in Piper Sandler's 36th Annual Healthcare Conference

Nov 13, 2024, 6:57 PM EST - 1 year ago

KORU Medical Systems, Inc. (KRMD) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 4:05 PM EST - 1 year ago

KORU Medical Systems, Inc. Announces 2024 Q3 Financial Results, Third Consecutive Quarter of Double-Digit Growth; Raises Full Year 2024 Guidance

Nov 6, 2024, 4:05 PM EST - 1 year ago

KORU Medical Systems to Participate in Upcoming Investor Conferences

Nov 6, 2024, 8:34 AM EST - 1 year ago

Impressive Turnaround At KORU Medical

Oct 31, 2024, 4:03 PM EDT - 1 year ago

KORU Medical Systems Presents Data at Partnership Opportunities in Drug Delivery (PODD) Conference Demonstrating Nursing Preference for Use of KORU FreedomEdge® Infusion System over Manual Syringe Administration for Subcutaneous Oncology Infusion

Oct 23, 2024, 4:05 PM EDT - 1 year ago

KORU Medical Systems to Report Third Quarter 2024 Financial Results on November 13, 2024

Sep 5, 2024, 7:00 AM EDT - 1 year ago

KORU Medical Systems to Participate in the 8th Annual Lake Street Best Ideas Growth Conference

Aug 7, 2024, 8:52 PM EDT - 1 year ago

KORU Medical Systems, Inc (KRMD) Q2 2024 Earnings Call Transcript

Aug 7, 2024, 4:05 PM EDT - 1 year ago

KORU Medical Systems, Inc. Announces 2024 Q2 Financial Results, a Record Quarter With 22% Revenue Growth; Raises Full Year 2024 Guidance

Jul 25, 2024, 4:05 PM EDT - 1 year ago

KORU Medical Systems to Participate in the Canaccord Genuity 44th Annual Growth Conference

Jul 24, 2024, 4:05 PM EDT - 1 year ago

KORU Medical Systems, Inc Announces Leadership Changes to Support Growth Agenda

Jul 17, 2024, 4:05 PM EDT - 1 year ago

KORU Medical Systems to Report Second Quarter 2024 Financial Results on August 7, 2024

Jul 2, 2024, 7:00 AM EDT - 1 year ago

KORU Medical Systems Receives Regulatory Clearance for FreedomEdge® Infusion System in Japan

Jun 5, 2024, 9:00 AM EDT - 1 year ago

Simplifying Subcutaneous Drug Administration: SCHOTT Pharma and KORU Medical Systems Announce Collaboration to Advance Large Volume Subcutaneous Infusion

Jun 4, 2024, 4:03 PM EDT - 1 year ago

KORU Medical Systems Announces a New Feasibility Study with a Commercialized Oncology Biologic

May 14, 2024, 4:05 PM EDT - 1 year ago

KORU Medical Systems Signs Supply Agreement for a Phase III Clinical Trial for a Novel Endocrinological Biologic

May 1, 2024, 10:11 PM EDT - 1 year ago

KORU Medical Systems, Inc. (KRMD) Q1 2024 Earnings Call Transcript

May 1, 2024, 4:05 PM EDT - 1 year ago

KORU Medical Systems, Inc. Announces 2024 First Quarter Financial Results Delivering Double-Digit Revenue Growth

Apr 17, 2024, 7:00 AM EDT - 1 year ago

KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024

Apr 11, 2024, 4:05 PM EDT - 1 year ago

KORU Medical Systems Announces Successful Appeal in EU Notified Body Review

Mar 18, 2024, 5:24 PM EDT - 1 year ago

KORU Medical Systems to Present Data Demonstrating 97% Adherence on Its Freedom Infusion System for Large Volume Subcutaneous Administration at NHIA 2024 Conference

Mar 13, 2024, 8:27 PM EDT - 1 year ago

KORU Medical Systems, Inc. (KRMD) Q4 2023 Earnings Call Transcript

Mar 13, 2024, 4:05 PM EDT - 1 year ago

KORU Medical Systems, Inc. Announces 2023 Fourth Quarter, Full Year Financial Results, and 2024 Guidance

Mar 11, 2024, 4:05 PM EDT - 1 year ago

KORU Medical Systems Announces a Feasibility Study to Enter Ambulatory Infusion Settings with a Commercialized Biologic

Mar 6, 2024, 7:00 AM EST - 1 year ago

KORU Medical Systems Signs a Clinical Supply Agreement for Phase 3 Trial with Leading Pharma Partner Using Custom Device for a Novel Subcutaneous Immunoglobulin

Feb 21, 2024, 7:00 AM EST - 1 year ago

KORU Medical Systems to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024

Nov 29, 2023, 7:00 AM EST - 2 years ago

KORU Medical Systems to Participate in Piper Sandler's 35th Annual Healthcare Conference

Nov 28, 2023, 8:00 AM EST - 2 years ago

KORU Medical Systems, Inc. to Host Investor Day on December 5, 2023

Nov 8, 2023, 8:12 PM EST - 2 years ago

KORU Medical Systems, Inc. (KRMD) Q3 2023 Earnings Call Transcript

Nov 8, 2023, 4:10 PM EST - 2 years ago

KORU Medical Systems, Inc. Announces Development Agreement for Next-generation Subcutaneous Immunoglobulin Infusion System

Doozio Oct. 23 at 1:20 PM

$KRMD it was always chop chop huckleberries 🐒🍌🧠⏰♾️

0 · Reply

StockChartsStudyholic Oct. 14 at 9:37 PM

$KRMD 👀

0 · Reply

IPO_Candy Oct. 10 at 8:36 PM

$KRMD Oh a green one!

0 · Reply

TradeNiko Oct. 5 at 9:27 AM

$KRMD Medical device innovation. Testing resistance at descending trendline. Volume pattern constructive for breakout.

0 · Reply

Gesundheit Sep. 16 at 2:21 PM

$KRMD Looks like we might hit another buy point. It is always sneaky and you have to be ready to hit or set a buy order.

0 · Reply

NVDAMillionaire Sep. 10 at 6:18 AM

0 · Reply

IPO_Candy Aug. 25 at 3:49 PM

$KRMD Added this one to the long term portfolio a few months ago. A keeper.

0 · Reply

Thestocktraderhubzee Aug. 7 at 6:15 PM

$KRMD KORU Medical Systems shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY25 sales guidance above estimates.

0 · Reply

Gesundheit Aug. 7 at 2:01 AM

$KRMD Nice earnings... https://seekingalpha.com/news/4480681-koru-medical-systems-gaap-eps-of-000-beats-by-003-revenue-of-102m-beats-by-074m

0 · Reply

Gesundheit Jul. 15 at 8:04 PM

1 · Reply

Gesundheit Jul. 7 at 8:11 PM

$KRMD https://investors.korumedical.com/news-events/press-releases/detail/178/koru-medical-systems-appoints-adam-kalbermatten-as-chief-commercial-officer

0 · Reply

davemn Jun. 28 at 2:51 AM

$KRMD 5.1M! shares today including after hours for the Russell addition. Should be a big back half of the year for Koru with all the 510k’s. Just getting started.

0 · Reply

StockScanners Jun. 28 at 2:47 AM

$KRMD Keep watch if this holds above 3.35

0 · Reply

copywrites Jun. 27 at 11:29 PM

$KRMD wow... Volume insane... something big is cooking 👀

0 · Reply

Thanman Jun. 27 at 9:40 PM

$KRMD took some here.

0 · Reply

prismmarketview Jun. 12 at 2:22 PM

$KRMD looks like it has a nice longterm base at $2

0 · Reply

Ccoussons Jun. 12 at 12:37 AM

$KRMD Added some today for a longerish swing play. Also $LEDS looking good right now.

0 · Reply

davemn May. 27 at 8:27 PM

$KRMD made the Russell additions list. Should move up in the coming weeks as it doesn't seem the arb's have purchased shares yet. we'll see.

1 · Reply

stoneblood May. 8 at 5:09 PM

$KRMD nice little scalp here

0 · Reply

stoneblood May. 8 at 12:06 PM

$KRMD dont sleep on this guiding cash flow positive for FY 2025 strong cash position and i dont see any warrants

0 · Reply

Gesundheit May. 7 at 8:29 PM

$KRMD https://investors.korumedical.com/news-events/press-releases/detail/176/koru-medical-systems-announces-record-q1-2025-financial-results-and-raises-2025-revenue-guidance

0 · Reply

Market Cap	196.04M
Revenue (ttm)	33.65M
Net Income (ttm)	-6.07M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-18.04%
Debt to Equity Ratio	0.00

Volume	25,500
Avg Vol	82,202
Day's Range	N/A - N/A
Shares Out	46.24M
Stochastic %K	81%
Beta	0.49
Analysts	Strong Sell
Price Target	$5.60